TCL Archive Groups Accepting Need for More Collaboration, NCI Backs Away From Drastic Structural Changes July 11, 1986
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006